title: Dexamethasone-eluting stents had sustained favorable ischemic driven target lesion revascularization rates over 5 years: a randomized controlled prospective study.
authors.forename: Yae Min
authors.initials: YM
authors.lastname: Park
authors.forename: Seung Hwan
authors.initials: SH
authors.lastname: Han
authors.forename: Kyounghoon
authors.initials: K
authors.lastname: Lee
authors.forename: Soon Yong
authors.initials: SY
authors.lastname: Suh
authors.forename: Pyung Chun
authors.initials: PC
authors.lastname: Oh
authors.forename: Wook-Jin
authors.initials: WJ
authors.lastname: Chung
authors.forename: Woong Chol
authors.initials: WC
authors.lastname: Kang
authors.forename: Kwang Kon
authors.initials: KK
authors.lastname: Koh
authors.forename: Tae Hoon
authors.initials: TH
authors.lastname: Ahn
authors.forename: In Suk
authors.initials: IS
authors.lastname: Choi
authors.forename: Eak Kyun
authors.initials: EK
authors.lastname: Shin
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage*; D054855:Drug-Eluting Stents; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000473:pathology; D009204:Myocardial Revascularization / Q000379:methods*; D011446:Prospective Studies; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D003907:Dexamethasone